scispace - formally typeset
D

Danica Novacic

Researcher at National Institutes of Health

Publications -  6
Citations -  516

Danica Novacic is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Missense mutation & Exome. The author has an hindex of 4, co-authored 5 publications receiving 152 citations.

Papers
More filters
Journal ArticleDOI

Somatic Mutations in UBA1 and Severe Adult-Onset Autoinflammatory Disease.

TL;DR: Using a genotype-driven approach, this disorder is identified that connects seemingly unrelated adult-onset inflammatory syndromes and is named the VEXAS (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) syndrome.
Journal ArticleDOI

De Novo Missense Variants in TRAF7 Cause Developmental Delay, Congenital Anomalies, and Dysmorphic Features

TL;DR: The findings suggest that missense mutations in TRAf7 are associated with a multisystem disorder and provide evidence of a role for TRAF7 in human development and suggest that missing amino acids in the protein are located in key functional domains.
Journal ArticleDOI

SGLT2 Inhibitors for Treatment of Refractory Hypomagnesemia: A Case Report of 3 Patients.

TL;DR: Dramatic improvement in serum magnesium levels and associated symptoms after initiating SGLT2 inhibitor therapy in 3 patients with refractory hypomagnesemia and diabetes is described, demonstrating a new tool in this challenging clinical disorder.
Journal ArticleDOI

ALPK1 missense pathogenic variant in five families leads to ROSAH syndrome, an ocular multisystem autosomal dominant disorder.

TL;DR: The heterozygous missense variant in the ɑ-kinase gene, ALPK1, was found and segregated with disease in all five families, leading to ROSAH syndrome, an autosomal dominant ocular systemic disorder.
Journal ArticleDOI

Case report: extreme coronary calcifications and hypomagnesemia in a patient with a 17q12 deletion involving HNF1B.

TL;DR: Several physiologic mechanisms and a review of literature are described to support the expansion of the 17q12 deletion syndrome to include vascular calcification, particularly if hypomagnesemia and hyperparathyroidism are prevalent.